Commercial Counsel at Iterative Health

Cambridge, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Life SciencesIndustries

Requirements

3-5 years of role-relevant post-bar experience in the life sciences and healthcare space, either in-house at a life sciences company or at a law firm
Familiarity with the healthcare and/or life sciences legal space, including understanding of industry-specific regulatory and commercial considerations such as HIPAA Privacy Rule and AKB
Experience negotiating clinical trial agreements with research institutions, CROs, and pharmaceutical companies
A J.D. from an ABA-accredited law school and active member in good standing with a state bar
Model excellence with humility, and do all that you can to help the broader team around you excel
Team player who dives head first into accepting diverse and challenging assignments with excitement, rigor and tenacity
High integrity and excellent judgment; highly organized and adept at managing time-sensitive work streams
Welcome responsibility for and ownership of work product and high-impact projects
Preferred Qualifications
Experience with GDPR and international privacy laws, including practical experience with data transfer mechanisms and cross-border compliance
Experience managing relationships with international outside counsel and coordinating legal strategies across multiple jurisdictions

Responsibilities

Draft, review, and negotiate a range of commercial and life sciences agreements to support the growth of the business and protect the interests of the company, including cross-border transactions, services agreements, and clinical trial agreements
Drive excellence and efficiency by refining and improving contract flow and compliance processes in close partnership with cross-functional stakeholders, including our people and finance teams
Drive the successful completion of multiple time-sensitive and impactful work streams
Communicate effectively and persuasively across and outside of the organization
Navigate international privacy and data protection requirements

Skills

Contract Drafting

Contract Negotiation

Commercial Agreements

Life Sciences Agreements

Clinical Trial Agreements

Healthcare Law

Data Privacy

Cross-border Transactions

Compliance Processes

Iterative Health

AI-driven solutions for gastrointestinal care

About Iterative Health

Iterative Health focuses on improving gastrointestinal (GI) care through the use of artificial intelligence (AI) and machine learning (ML). Their main product, SKOUT®, is an FDA-cleared device designed to help doctors detect adenomas, which are precursors to colorectal cancer. This device works alongside physician judgment to enhance the accuracy of diagnoses. In addition to SKOUT®, Iterative Health provides services that optimize clinical trials by using AI-enabled documentation technology, which improves patient care and ensures high-quality reporting across different healthcare institutions. This technology aims to make advanced care more accessible, especially to underserved populations. Unlike many competitors, Iterative Health combines AI technology with a strong focus on colorectal cancer prevention and clinical trial efficiency. The company's goal is to deliver top-tier GI care and improve health outcomes for patients worldwide.

Boston, MassachusettsHeadquarters

2017Year Founded

$182.1MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, HealthcareIndustries

51-200Employees

Benefits

Vision/Dental/ Medical Insurance

Life/Disability Insurance

Parental Leave

Stock Options

Flexible Work Hours

Unlimited Paid Time Off

Risks

Competition from tech giants in AI medical imaging threatens Iterative Health's market share.

Rapid expansion and partnerships may strain operational capabilities and resources.

Reliance on AI exposes Iterative Health to potential ethical and regulatory scrutiny.

Differentiation

Iterative Health uses AI to enhance GI care, focusing on colorectal cancer prevention.

Their SKOUT® device aids in adenoma detection, improving diagnostic accuracy in endoscopy.

AI-enabled documentation technology optimizes clinical trials, enhancing research quality and continuity.

Upsides

AI-driven predictive analytics in gastroenterology allow for personalized, effective patient care.

Partnerships with Gastro Health and One GI® expand clinical research capabilities in GI care.

$150M Series B funding accelerates AI innovations, transforming gastroenterology care.

Land your dream remote job 3x faster with AI

Try Jobo Free